Track the Mereo BioPharma Group plc share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €54.7m. The latest transaction was filed on 16 September 2024 (Cession). Among the most active insiders: Hughes-Wilson Alexandra. Every trade is accessible without an account.
24
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€539,820
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Mereo BioPharma Group plc Buy (bullish), based on 5 analysts. Average price target: US$1.98.
59Σ signal
Buys n/a€539,820 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
93,333 shares@ US$1.4064.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-064274:0
24 of 24 declarations
Acerca de Mereo BioPharma Group plc
Mereo BioPharma Group plc es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades raras y trastornos relacionados con la edad. Cotiza en NASDAQ bajo el símbolo MREO.